Prokarium Ltd   Report issue

For profit Phase 1
Founded: London United Kingdom (2007)

Organization Overview

First Clinical Trial
2019
NCT04349553
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2024

Timeline

NOW
  • Now

Alternative names

Prokarium Ltd

Active Ingredients

Drugs in Phase 1 Trials (3)

live attenuated S. enterica serovar Typhi ZH9 (1 trial)

m01zh09 (1 trial)

zh9pa (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Fever (Phase 1)

Typhoid Fever (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 2
  • # of Trial APIs: 3